You have 9 free searches left this month | for more free features.

methotrexate

Showing 26 - 50 of 944

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

PCNSL Trial in Shanghai (Zanubrutinib, Rituximab, Methotrexate)

Not yet recruiting
  • PCNSL
  • Shanghai, Shanghai, China
    Ruijin Hospital
Jun 8, 2023

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein

Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +7 more
  • Blinatumomab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 31, 2022

Primary CNS Lymphoma, PCNSL, Non Hodgkin Lymphoma Trial in Guandong, Guangzhou (Methotrexate, Ibrutinib, Temozolomide)

Recruiting
  • Primary Central Nervous System Lymphoma
  • +2 more
  • Methotrexate
  • +2 more
  • Guandong, Guangdong, China
  • +2 more
Apr 6, 2022

Rheumatoid Arthritis Trial (Brodalumab, Placebo, Methotrexate)

Completed
  • Rheumatoid Arthritis
  • (no location specified)
Nov 22, 2021

Rheumatoid Arthritis Trial in Sweden (Methotrexate)

Recruiting
  • Rheumatoid Arthritis
  • Methotrexate
  • Eskilstuna, Sweden
  • +10 more
Jun 28, 2022

Arthritis, Juvenile Trial in Worldwide (Golimumab, Methotrexate)

Active, not recruiting
  • Arthritis, Juvenile
  • San Diego, California
  • +37 more
Jan 17, 2023

Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, ph+ Acute Lymphoblastic Leukemia Trial in Chicago (Inotuzumab ozogamicin,

Recruiting
  • Lymphoblastic Leukemia
  • +2 more
  • Inotuzumab ozogamicin
  • +7 more
  • Chicago, Illinois
    University of Chicago Medical Center
May 16, 2022

Healthy Trial in Dallas (LY3871801, Methotrexate, Warfarin)

Recruiting
  • Healthy
  • Dallas, Texas
    Covance Dallas
Dec 26, 2022

Hypophosphatasia Trial (methotrexate, rituximab, bortezomib)

Not yet recruiting
  • Hypophosphatasia
  • methotrexate
  • +4 more
  • (no location specified)
Aug 23, 2023

Non-hodgkin Lymphoma Trial (Methotrexate, Rituximab (where available), Ibrutinib)

Not yet recruiting
  • Non-hodgkin Lymphoma
  • Methotrexate
  • +2 more
  • (no location specified)
Aug 11, 2023

Takayasu Arteritis Trial in Shanghai (Tofacitinib, Methotrexate)

Recruiting
  • Takayasu Arteritis
  • Shanghai, Shanghai, China
    Lindi Jiang
Oct 19, 2021

Uveitis Trial in Spain (Methotrexate, Adalimumab, Adalimumab+Methotrexate)

Recruiting
  • Uveitis
  • Methotrexate
  • +2 more
  • A Coruña, Spain
  • +13 more
Mar 15, 2022

ive Alzheimer's Medicines - Methotrexate vs Hydroxychloroquine

Completed
  • Rheumatoid Arthritis
  • Boston, Massachusetts
    Brigham and Women's Hospital
Nov 15, 2021

Psoriatic Arthritis Trial in Frankfurt am Main (Methotrexate, Ustekinumab, Placebo)

Completed
  • Psoriatic Arthritis
  • Methotrexate
  • +2 more
  • Frankfurt am Main, Hessia, Germany
    CIRI
Mar 1, 2022

Low Dose Methotrexate in Severe Chronic Asthma Trial (Methotrexate, Placebo)

Not yet recruiting
  • Low Dose Methotrexate in Severe Chronic Asthma
  • Methotrexate
  • Placebo
  • (no location specified)
Sep 27, 2021

Acute Lymphoblastic Leukemia (ALL) in Partial Remission, Acute Lymphoblastic Leukemia (ALL) in Complete Remission, Acute Myeloid

Recruiting
  • Acute Lymphoblastic Leukemia (ALL) in Partial Remission
  • +2 more
  • Cyclophosphamide 50mg
  • Methotrexate
  • Riyadh, Saudi Arabia
    King Faisal Specialist Hospital & Research Center
Apr 4, 2022

Rates of Dementia and Alzheimer's Disease in Participants

Completed
  • Dementia
  • Alzheimer Disease
  • Titusville, New Jersey
    Janssen R&D
Oct 15, 2021

GTD, Gestational Trophoblastic Neoplasia, Stage I GTD Trial in Beijing (Methotrexate, Leucovorin, Dactinomycin)

Recruiting
  • Gestational Trophoblastic Tumor
  • +6 more
  • Methotrexate
  • +2 more
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Nov 14, 2021

Rheumatoid Arthritis, Rheumatic Diseases Trial in Leiden (Abatacept, Methotrexate)

Completed
  • Rheumatoid Arthritis
  • Rheumatic Diseases
  • Leiden, Netherlands
    Leiden University Medical Center
Aug 16, 2022

MDS, de Novo, MDS, Secondary, MDS, Previously Treated Trial in Boston (Venetoclax, Azacitidine, Cytarabine)

Recruiting
  • Myelodysplastic Syndromes, de Novo
  • +10 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 23, 2023

Head and Neck Squamous Cell Cancer Trial (pembrolizumab, methotrexate, docetaxel)

Completed
  • Head and Neck Squamous Cell Cancer
  • pembrolizumab
  • +3 more
  • (no location specified)
Aug 24, 2022

HIV Trial in United States (Lamivudine, Methotrexate, Zidovudine)

Completed
  • HIV Infections
  • Los Angeles, California
  • +6 more
Oct 27, 2021

Localized Osteosarcoma, Metastatic Osteosarcoma, Resectable Osteosarcoma Trial (Bone Scan, Cabozantinib S-malate, Cisplatin)

Not yet recruiting
  • Localized Osteosarcoma
  • +3 more
  • Bone Scan
  • +7 more
  • (no location specified)
Jan 18, 2023

Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Cleveland (tacrolimus, methotrexate,

Active, not recruiting
  • Chronic Myelogenous Leukemia
  • +9 more
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Aug 4, 2021

Acute GVH Disease Trial in Beijing (Methotrexate)

Recruiting
  • Acute GVH Disease
  • Methotrexate
  • Beijing, Beijing, China
    Peking University Institute of Hematology,Beijing
Sep 14, 2021